From Medscape Oncology

Medscape Medical News from the:

2014 Gastrointestinal Cancers Symposium (GICS)

January 16 - 18, 2014; San Francisco, California

This coverage is not sanctioned by, nor a part of, the American Gastroenterological Association, the American Society of Clinical Oncology, the American Society for Radiation Oncology, or the Society of Surgical Oncology.

Conference News

GICS Maintenance Chemo Delays Progression in Metastatic CRC
Medscape Medical News, January 27, 2014
GICS Diagnostic Tool and Biomarker Promising in Pancreatic Cancer
Medscape Medical News, January 23, 2014
GICS Survival No Better With Aspirin in Colorectal Cancer Subset
Medscape Medical News, January 23, 2014
GICS A New, Simpler Standard of Treatment in Rectal Cancer
Medscape Medical News, January 21, 2014
GICS New Assay Predicts Treatment Resistance in Esophageal Cancer
Medscape Medical News, January 21, 2014
GICS Postop Complications Cut Survival in Gastric Cancer
Medscape Medical News, January 17, 2014
GICS No Benefit to Adding Cetuximab in Esophageal Cancer
Medscape Medical News, January 17, 2014
GICS Unprecedented Responses Seen in Neuroendocrine Tumors
Medscape Medical News, January 15, 2014
GICS 'Exciting Results' in Poor-Prognosis Pancreatic Cancer
Medscape Medical News, January 14, 2014
GICS Antiangiogenic Extends Survival in Advanced Gastric Cancer
Medscape Medical News, January 14, 2014

Medscape Oncology© WebMD, LLC

Previous Coverage